Cortec Group brings resources with diverse experiences to assess and quickly close investments and to add real value to our companies post-closing.
The same group that performs due diligence stays with each company throughout our investment. Management views us as an extension of their team and equally dedicated to their success.
We have well-rounded teams comprised of professionals with business and transaction experience who are dedicated to rapidly understanding the companies we review.
Former executives and entrepreneur-partners have committed significant capital to Cortec’s funds, complementing our stable base of blue-chip limited partners.
We have consistently delivered top quartile (or better) returns under Cortec's leadership team.
We are highly discerning regarding which companies we visit and pursue.
We interact and communicate regularly with our management teams, without the need for formal board meetings or high-level presentations.
We invest in highly-profitable middle-market specialty healthcare, B2C and B2B products, distribution, eCommerce, and services companies with revenues of $40-$300 million, strong cash flows, and identified opportunities for Cortec Group to add value.